| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K97651142 |
| PharmacoGx | BRD-K97651142 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GFOD2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | PTPRB | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | TPD52L2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | PPM1J | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | PROM2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | RFESD | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PLK3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | KRTAP10-2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | EIF3J | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | NPEPPS | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
